Ionis Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Ionis Pharmaceuticals
IONS Stock  USD 32.95  1.35  3.94%   
Ionis Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Ionis Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Ionis Pharmaceuticals financial statements helps investors assess Ionis Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Ionis Pharmaceuticals' valuation are summarized below:
Gross Profit
-207.6 M
Profit Margin
(0.64)
Market Capitalization
5.5 B
Enterprise Value Revenue
6.4765
Revenue
705.1 M
There are over one hundred nineteen available fundamental trends for Ionis Pharmaceuticals, which can be analyzed over time and compared to other ratios. All traders should confirm Ionis Pharmaceuticals' regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 6.8 B in 2025. Enterprise Value is likely to gain to about 7.8 B in 2025

Ionis Pharmaceuticals Total Revenue

740.39 Million

Check Ionis Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ionis Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 27.2 M, Interest Expense of 88.6 M or Total Revenue of 740.4 M, as well as many indicators such as Price To Sales Ratio of 7.04, Dividend Yield of 0.0 or PTB Ratio of 8.44. Ionis financial statements analysis is a perfect complement when working with Ionis Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Ionis Pharmaceuticals Correlation against competitors.
For more information on how to buy Ionis Stock please use our How to Invest in Ionis Pharmaceuticals guide.

Ionis Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.2 B3 B1.8 B
Slightly volatile
Short and Long Term Debt Total1.5 B1.4 B735.7 M
Slightly volatile
Total Current Liabilities324.8 M309.3 M209.4 M
Slightly volatile
Total Stockholder Equity617.8 M588.4 M495.2 M
Slightly volatile
Property Plant And Equipment Net268.9 M256.1 M146.2 M
Slightly volatile
Cash230 M242.1 M984 M
Slightly volatile
Non Current Assets Total402.6 M383.4 M239.5 M
Slightly volatile
Non Currrent Assets Other133.6 M127.3 M75.5 M
Slightly volatile
Cash And Short Term Investments2.4 B2.3 B1.4 B
Slightly volatile
Common Stock Shares Outstanding86.2 M149.5 M117.5 M
Slightly volatile
Liabilities And Stockholders Equity3.2 B3 B1.8 B
Slightly volatile
Non Current Liabilities Total2.2 B2.1 B1.1 B
Slightly volatile
Other Current Assets228.8 M217.9 M99.9 M
Slightly volatile
Other Stockholder Equity3 B2.9 B1.7 B
Slightly volatile
Total Liabilities2.5 B2.4 B1.3 B
Slightly volatile
Total Current Assets2.8 B2.6 B1.5 B
Slightly volatile
Short Term Debt64.2 M61.1 M32.9 M
Slightly volatile
Intangible Assets24.2 M33.4 M22.8 M
Slightly volatile
Accounts Payable45.1 M43 M20.6 M
Slightly volatile
Net Receivables96.8 M92.2 M48.2 M
Slightly volatile
Property Plant And Equipment Gross380.5 M362.4 M173.1 M
Slightly volatile
Short Term Investments2.2 B2.1 B975.1 M
Slightly volatile
Other Assets57.3 M40.2 M76.8 M
Slightly volatile
Long Term Debt1.3 B1.2 B675.9 M
Slightly volatile
Common Stock Total Equity110.1 K163.3 K122.5 K
Slightly volatile
Property Plant Equipment79.6 M85.4 M103.1 M
Slightly volatile
Other Liabilities170 M330.9 M226.4 M
Slightly volatile
Current Deferred Revenue71.9 M79 M81.3 M
Slightly volatile
Inventory10.8 M12.5 M13 M
Slightly volatile
Net Tangible Assets531.9 M658.8 M503.1 M
Slightly volatile
Long Term Debt Total1.4 B1.4 B679.7 M
Slightly volatile
Capital Surpluse1.7 B2.4 B1.6 B
Slightly volatile
Deferred Long Term Liabilities96.7 M83.6 M82.5 M
Very volatile
Non Current Liabilities Other289.3 M542.2 M229.3 M
Slightly volatile
Short and Long Term Debt8.8 M9.3 M26.6 M
Pretty Stable
Net Invested Capital1.9 B1.8 B1.4 B
Slightly volatile
Net Working Capital2.1 B2.3 B1.5 B
Slightly volatile
Capital Stock157.6 K158 K141.5 K
Slightly volatile
Deferred Long Term Asset Charges232.6 M261.7 M285.3 M
Slightly volatile
Long Term Investments8 M9 M9.8 M
Slightly volatile

Ionis Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization27.2 M25.9 M14.5 M
Slightly volatile
Total Revenue740.4 M705.1 M486.5 M
Slightly volatile
Other Operating Expenses1.2 B1.2 B610.1 M
Slightly volatile
Cost Of Revenue10.7 M11.2 M107.4 M
Slightly volatile
Total Operating Expenses1.2 B1.2 B605.2 M
Slightly volatile
Research Development946.6 M901.5 M465.5 M
Slightly volatile
Selling General Administrative280.9 M267.5 M142.5 M
Slightly volatile
Selling And Marketing Expenses22.2 K23.4 K10.7 M
Slightly volatile
Non Operating Income Net Other193.6 M184.4 M54 M
Slightly volatile
Interest Income2.9 M3.1 M11.3 M
Slightly volatile
Reconciled Depreciation19.3 M22 M13.6 M
Slightly volatile

Ionis Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow419.2 M399.3 M264.5 M
Slightly volatile
Depreciation10.5 M19.7 M13.1 M
Slightly volatile
Capital Expenditures47.5 M45.3 M21.9 M
Slightly volatile
End Period Cash Flow176.1 M242.1 M264.1 M
Slightly volatile
Stock Based Compensation136.7 M130.2 M86.6 M
Slightly volatile
Issuance Of Capital Stock548.9 M522.7 M347.1 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.047.412714.8032
Slightly volatile
PTB Ratio8.448.884217.1333
Slightly volatile
Days Sales Outstanding45.3347.7192174
Slightly volatile
Book Value Per Share2.243.93513.7962
Slightly volatile
Stock Based Compensation To Revenue0.10.18460.1552
Slightly volatile
Capex To Depreciation2.422.30391.6991
Pretty Stable
PB Ratio8.448.884217.1333
Slightly volatile
EV To Sales15.379.065214.458
Slightly volatile
Inventory Turnover0.850.896317.0847
Slightly volatile
Days Of Inventory On Hand434407470
Slightly volatile
Payables Turnover0.250.2617.3122
Slightly volatile
Sales General And Administrative To Revenue0.40.37940.2394
Slightly volatile
Research And Ddevelopement To Revenue1.671.27851.1972
Slightly volatile
Capex To Revenue0.0610.06420.0747
Slightly volatile
Cash Per Share16.1415.367514.4371
Slightly volatile
Days Payables Outstanding1.5 K1.4 K795
Slightly volatile
Intangibles To Total Assets0.01210.01280.0183
Slightly volatile
Current Ratio4.518.47126.5069
Slightly volatile
Tangible Book Value Per Share2.03.93513.6525
Slightly volatile
Receivables Turnover7.277.648927.987
Slightly volatile
Shareholders Equity Per Share2.143.93513.5844
Slightly volatile
Debt To Equity2.272.39191.7143
Slightly volatile
Capex Per Share0.320.30280.1786
Slightly volatile
Revenue Per Share4.954.71623.6028
Slightly volatile
Interest Debt Per Share10.489.97665.3774
Slightly volatile
Debt To Assets0.340.46850.3718
Slightly volatile
Graham Number13.8620.0519.3371
Slightly volatile
Operating Cycle325455633
Very volatile
Price Book Value Ratio8.448.884217.1333
Slightly volatile
Days Of Payables Outstanding1.5 K1.4 K795
Slightly volatile
Company Equity Multiplier4.855.10524.0802
Slightly volatile
Long Term Debt To Capitalization0.420.70520.5369
Slightly volatile
Total Debt To Capitalization0.450.70520.5502
Slightly volatile
Debt Equity Ratio2.272.39191.7143
Slightly volatile
Quick Ratio4.478.43076.45
Slightly volatile
Cash Ratio0.740.78264.7228
Very volatile
Days Of Inventory Outstanding434407470
Slightly volatile
Days Of Sales Outstanding45.3347.7192174
Slightly volatile
Price To Book Ratio8.448.884217.1333
Slightly volatile
Fixed Asset Turnover2.232.75333.0558
Slightly volatile
Debt Ratio0.340.46850.3718
Slightly volatile
Price Sales Ratio7.047.412714.8032
Slightly volatile
Asset Turnover0.180.23480.2758
Pretty Stable
Price Fair Value8.448.884217.1333
Slightly volatile

Ionis Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap6.8 B6.5 B7 B
Slightly volatile
Enterprise Value7.8 B7.5 B6.9 B
Slightly volatile

Ionis Fundamental Market Drivers

Forward Price Earnings90.9091
Cash And Short Term Investments2.3 B

Ionis Upcoming Events

28th of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
28th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ionis Pharmaceuticals Financial Statements

Ionis Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Ionis Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Ionis Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Ionis Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue79 M71.9 M
Total Revenue705.1 M740.4 M
Cost Of Revenue11.2 M10.7 M
Stock Based Compensation To Revenue 0.18  0.10 
Sales General And Administrative To Revenue 0.38  0.40 
Research And Ddevelopement To Revenue 1.28  1.67 
Capex To Revenue 0.06  0.06 
Revenue Per Share 4.72  4.95 
Ebit Per Revenue(0.67)(0.71)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Ionis Stock Analysis

When running Ionis Pharmaceuticals' price analysis, check to measure Ionis Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ionis Pharmaceuticals is operating at the current time. Most of Ionis Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Ionis Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ionis Pharmaceuticals' price. Additionally, you may evaluate how the addition of Ionis Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY